Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 3, 2008, Pages 467-473

  Park, Kyung Woo ^a   Park, Joong Won ^a   Choi, Jun Il ^a   Kim, Tae Hyun ^a   Kim, Seong Hoon ^a   Park, Hong Suk ^a   Lee, Woo Jin ^a   Park, Sang Jae ^a   Hong, Eun Kyung ^a   Kim, Chang Min ^a  

^a National Cancer Center   (South Korea)

Author keywords

Hepatocellular carcinoma; Prognosis; Survival; Therapeutics

Indexed keywords

ALPHA FETOPROTEIN; CAPECITABINE; CISPLATIN; DOXORUBICIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMOEMBOLIZATION; CHEMOTHERAPY; CHILD PUGH CLASS A; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; INTERNATIONAL UNION AGAINST CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR THROMBUS; VASCULAR TUMOR;

EID: 40349095123     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05112.x     Document Type: Article

References (33)